EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • March 9th, 2010 • AspenBio Pharma, Inc. • In vitro & in vivo diagnostic substances • Colorado
THIS AGREEMENT dated as of the 19th day of January 2010, to be effective as of the 1st day of January 2010, by and between, AspenBio Pharma, Inc., a Colorado corporation (the "Employer" or "Company") and Gregory L. Bennett (the "Executive"). In consideration of the mutual covenants contained in this Agreement, the Employer agrees to employ the Executive and the Executive agrees to be employed by the Employer upon the terms and conditions hereinafter set forth.
AspenBio Pharma, Inc. Stock Option AgreementStock Option Agreement • March 9th, 2010 • AspenBio Pharma, Inc. • In vitro & in vivo diagnostic substances • Colorado
AspenBio Pharma, Inc., a Colorado corporation (the “Company”), desiring to provide to the person named below (the “Optionee”) an opportunity for an investment in the Company and additional Option to pursue the success of the Company, hereby grants to the Optionee, and the Optionee hereby accepts, an incentive stock option (the “Option”) pursuant to the Company’s 2002 Stock Incentive Plan, as amended (the “Plan”) to purchase the number of shares as specified below (the “Option Shares”), during the term ending at midnight (prevailing local time at the Company’s principal office) on the expiration date of the Option specified below, at the option exercise price specified below subject to and upon the following terms and conditions:
SETTLEMENT AND RELEASE AGREEMENTSettlement Agreement • March 9th, 2010 • AspenBio Pharma, Inc. • In vitro & in vivo diagnostic substances • Georgia
This Settlement and Release Agreement (“Settlement Agreement”) is made this December 31, 2009, by and between Merial Limited, a company limited by shares registered in England and Wales (registered number 3332751), with a registered office at P.O. Box 327, Sandringham House, Sandringham Avenue, Harlow Business Park, Harlow, Essex CM19 5QA, England, and domesticated in Delaware, USA, as Merial LLC with a place of business at 3239 Satellite Boulevard, Duluth, Georgia 30096-4640 (“Merial”), and AspenBio Pharma, Inc., (formerly known as “AspenBio, Inc.) with an address of 1585 South Perry Street, Castle Rock, CO 80104 (“AspenBio”).
